Anti-oxidant effect of metformin through AMPK/SIRT1/PGC-1α/SIRT3- independent GPx1 expression in the heart of mice with endometriosis
- PMID: 35796227
- DOI: 10.1515/hmbci-2022-0039
Anti-oxidant effect of metformin through AMPK/SIRT1/PGC-1α/SIRT3- independent GPx1 expression in the heart of mice with endometriosis
Abstract
Objectives: Endometriosis is a gynecological disease associated with an imbalance between oxidative species production and anti-oxidative defenses. In women, endometriosis has been reported to associate with increased incidence of cardiovascular events. As such, this study aimed to analyze the oxidation-responsive AMPK/SIRT1/PGC-1α/SIRT3 pathway in the heart of a mouse model of endometriosis. The effect of metformin, an insulin-sensitizing and anti-oxidative drug with already shown positive results in endometriotic tissue was studied.
Methods: Thirty-six female B6CBA/F1 mice were divided into 4 groups (Control-C, Surgery-induced Endometriosis and Metformin-EM (50 mg/kg/day orally administrated for 3 months), Endometriosis-E and Metformin-M). Immunofluorescent labelling of SIRT1 and SIRT3 was performed in the heart tissue. Assessment of expression of AMPKα, SIRT1, PGC-1α, SIRT3, SOD2, and GPx1 was performed by Western Blotting. The quantification of microRNA(miR)-34a, miR-195, miR-217, miR-155 and miR-421, involved in the regulation of expression of SIRT1 and SIRT3, was performed by Real-Time PCR.
Results: Data showed an increase in phospho-AMPKα and in GPx1 expression in the EM group when compared to the C group, but not in the total AMPK, SIRT1, PGC-1α, SIRT3 and SOD2, suggesting a GPx1 expression increase independently of the AMPK/SIRT1/PGC-1α/SIRT3 pathway. MicroRNAs, excepting miR-217, showed a consistent trend of increase in the M group.
Conclusions: Our study showed that endometriosis does not significantly affect the expression of the components of the AMPK/SIRT1/PGC-1α/SIRT3 pathway in the heart. However, it indicates that an oxidative condition underlying endometriosis is required for metformin to evidence an increment in the expression of the anti-oxidative enzyme GPx1.
Keywords: AMPK; cardiovascular disease; endometriosis; glutathione peroxidase 1; metformin.
© 2022 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Hickey, M, Ballard, K, Farquhar, C. Endometriosis. BMJ: Br Med J 2014;348:g1752. https://doi.org/10.1136/bmj.g1752.
-
- Kvaskoff, M, Mu, F, Terry, KL, Harris, HR, Poole, EM, Farland, L, et al.. Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update 2015;21:500–16. https://doi.org/10.1093/humupd/dmv013.
-
- Mu, F, Rich-Edwards, J, Rimm, EB, Spiegelman, D, Missmer, SA. Endometriosis and risk of coronary heart disease. Circ: Cardiovasc Qual Outcomes 2016;9:257–64. https://doi.org/10.1161/circoutcomes.115.002224.
-
- Sourial, S, Tempest, N, Hapangama, DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med 2014;2014:179515. https://doi.org/10.1155/2014/179515.
-
- Szczepańska, M, Koźlik, J, Skrzypczak, J, Mikołajczyk, M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 2003;79:1288–93. https://doi.org/10.1016/s0015-0282(03)00266-8.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous